A company that makes a home-based urine analysis kit that utilizes a test strip and a user’s smartphone has raised $18 million in Series B funding. The announcement from Israel-based Healthy.io comes on the heels of FDA clearance for its kit, which the company hopes will appeal to the one-in-three American adults at risk of kidney disease.
Digital urinalysis is the latest example of a trend toward home diagnostics driving a surging medical technology market. The first at-home pregnancy test appeared in the late 1970s, paving the way for a home-based medical test market. More recently, the internet, IoT, smartphones, and advances in areas like genetic testing have driven sharp growth in a home testing market that will soon surpass $300 million.